Astellas Pharma Inc. and Pantherna Therapeutics GmbH announced that the companies have entered into a new technology evaluation agreement for research to generate mRNA-based...
Astellas Pharma Inc. announced plans to create an integrated biotechnology campus in South San Francisco as its West Coast innovation and research center. The...
Astellas Pharma Inc. (President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and GO Therapeutics, Inc. (Co-Founder and CEO: Constantine Theodoropulos, "GO") announced that Xyphos Biosciences,...
Exopharm Limited has signed a Master Collaborative Services Agreement (MSA) with the Astellas Institute for Regenerative Medicine (AIRM).
Also Read: Novavax and Israel Announce Advance...
